ABD-3001

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameABD-3001
Drug Alias NameABD-3001
ClassificationSmall molecules
Mechanisms of ActionApoptosis stimulantsAldehyde Dehydrogenase 1 Family Member A1 inhibitorsRetinal dehydrogenase 2 inhibitors
TargetsAldehyde Dehydrogenase 1 Family Member A1Retinal dehydrogenase 2
Therapy Area/IndicationsMyelodysplastic SyndromesCarcinoma, Non-Small-Cell LungBreast Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdvanced BioDesign
China Registration ClassN/A

Develop Information

Active CompaniesAdvanced BioDesignOdyssey Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesCarcinoma, Non-Small-Cell LungBreast Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A